Estrogen inhibitors likely to serve as cervical cancer treatments, study suggests
December 6, 2005
Landmark evidence suggests estrogen may be one of the causative agents in cervical cancer, according to a research team at the Health Science Center. The results, published in the Dec. 1 issue of Cancer Research, raise the possibility that estrogen inhibitors could be used as a potential line of therapy to treat cervical cancer.